Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Public Reimbursement Policies for Oncology Medicines in Canada

There may be opportunities for future alignment of oncology medication funding policies across public drug plans in Canada, including alignment of definitions for hospital-administered, take-home, and supportive care.

Cda-Amc · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.